fr

CARMAT completes enrolment in the EFICAS clinical study and receives approval from French authorities for 21 additional Aeson® implants, while awaiting potential reimbursement of the device in France

CARMAT announces the success of its IPO

Download

CARMAT launches its IPO

Download

CARMAT announces the registration of its Document de Base

Download
Top of page